3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
CNS
1
Conditions
Breast Neoplasms
10
Prostatic Neoplasms
7
Sarcoma
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Pancreatic Neoplasms
3
Carcinoma, Intraductal, Noninfiltrating
3
Urinary Bladder Neoplasms
2
Endometrial Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Breast Carcinoma In Situ
2
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder Diseases
1
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Prostate Adenocarcinoma
1
Pituitary Neoplasms
1
Neurilemmoma
1
Nerve Sheath Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Metastasis
1
Meningioma
1
Male Urogenital Diseases
1
Lymphedema
1
Interventions
pazopanib
2
Proton Therapy
2
Ifosfamide
2
Doxorubicin
2
tazemetostat
1
selinexor
1
Zoledronic Acid
1
Radiotherapy
1
Radiation Dose Hypofractionation
1
Radiation
1
Protons
1
Nivolumab
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Nerve Sheath Neoplasms
×
Radiation Dose Hypofractionation
×
1 year
×
Clear all
NCT04278118
2026-02-17
HiPPI
Emory University
Phase NA
Recruiting
70 enrolled